EBV plus Diffuse Large B-Cell Lymphoma, NOS Shows Over-Expression of PD-L1/PD-1

被引：0

作者：

Jagannathan, Geetha ^{[1
]}

Gong, Jerald ^{[1
]}

Uppal, Guldeep ^{[1
]}

机构：

[1] Thomas Jefferson Med Coll, Philadelphia, PA USA

来源：

LABORATORY INVESTIGATION | 2018年 / 98卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

1475

引用

页码：525 / 525

页数：1

共 50 条

[31] PD-1, PD-L1 and PD-L2 Expression in Mantle Cell Lymphoma and Healthy Population [J].

Karolova, J. ;

Radek, M. ;

Helman, K. ;

Spacek, M. ;

Trneny, M. ;

Klener, P. .

FOLIA BIOLOGICA, 2020, 66 (04) :117-122

[32] PD-L1 expression in anaplastic large cell lymphoma [J].

Kong, Jianping ;

Dasari, Surendra ;

Feldman, Andrew L. .

MODERN PATHOLOGY, 2020, 33 (06) :1232-1233

[33] Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells [J].

Dong, Ling ;

Lv, Huijuan ;

Li, Wei ;

Song, Zheng ;

Li, Lanfang ;

Zhou, Shiyong ;

Qiu, Lihua ;

Qian, Zhengzi ;

Liu, Xianming ;

Feng, Lixia ;

Meng, Bin ;

Fu, Kai ;

Wang, Xi ;

Pan-Hammarstrom, Qiang ;

Wang, Ping ;

Wang, Xianhuo ;

Zhang, Huilai .

ONCOTARGET, 2016, 7 (22) :33350-33362

[34] Co-expression of PD-L1 and p-AKT is associated with poor prognosis in diffuse large B-cell lymphoma via PD-1/PD-L1 axis activating intracellular AKT/mTOR pathway in tumor cells [J].

Zhang, H. ;

Wang, X. ;

Dong, L. ;

Lv, H. ;

Li, W. ;

Song, Z. ;

Li, L. ;

Zhou, S. ;

Qiu, L. ;

Qian, Z. ;

Liu, X. ;

Feng, L. ;

Meng, B. ;

Fu, K. ;

Wang, X. ;

Pan-Hammarstrom, Q. ;

Wang, P. .

ANNALS OF ONCOLOGY, 2016, 27

[35] PD-1–PD-L1 immune-checkpoint blockade in B-cell lymphomas [J].

Aaron Goodman ;

Sandip P. Patel ;

Razelle Kurzrock .

Nature Reviews Clinical Oncology, 2017, 14 :203-220

[36] EXPRESSION OF PD-1 AND PD-L1 IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH PRE-EXISTING RHEUMATOID ARTHRITIS - A POSSIBLE ASSOCIATION WITH HIGH RHEUMATOID ARTHRITIS DISEASE ACTIVITY [J].

Hellbacher, E. ;

Sundstrom, C. ;

Molin, D. ;

Baecklund, E. ;

Hollander, P. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :584-584

[37] PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas [J].

Pascual, Marien ;

Mena-Varas, Maria ;

Francisco Robles, Eloy ;

Garcia-Barchino, Maria-Jose ;

Panizo, Carlos ;

Hervas-Stubbs, Sandra ;

Alignani, Diego ;

Sagardoy, Ainara ;

Ignacio Martinez-Ferrandis, Jose ;

Bunting, Karen L. ;

Meier, Stephen ;

Sagaert, Xavier ;

Bagnara, Davide ;

Guruceaga, Elizabeth ;

Blanco, Oscar ;

Celay, Jon ;

Martinez-Baztan, Alvaro ;

Casares, Noelia ;

Jose Lasarte, Juan ;

MacCarthy, Thomas ;

Melnick, Ari ;

Angel Martinez-Climent, Jose ;

Roa, Sergio .

BLOOD, 2019, 133 (22) :2401-2412

[38] PD-L1 Expression Identifies High Risk Diffuse Large B-Cell Lymphoma and Is Associated with Several Genomic Markers [J].

Siddiqi, Imran N. ;

Thodima, Venkata ;

Friedman, Julia ;

Violeta, Adames ;

Tulpule, Anil ;

Shaknovich, Rita ;

Houldsworth, Jane .

BLOOD, 2016, 128 (22)

[39] The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis [J].

Qiu, Liping ;

Zheng, Hanlu ;

Zhao, Xiaoying .

BMC CANCER, 2019, 19 (1)

[40] The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis [J].

Liping Qiu ;

Hanlu Zheng ;

Xiaoying Zhao .

BMC Cancer, 19

← 1 2 3 4 5 →